Clinical trial
The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart Failure: an Open Label, Randomized, Blank-controlled Study.
NCT05008679 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart Failure: an Open Label, Randomized, Blank-controlled Study.
- Lead sponsor
- Tongji Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 25, 2021
- Completion date
- January 25, 2024
- Enrollment
- 388 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.